HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus.

Abstract
The aim was to study the association of smoking with the activity and severity of systemic lupus erythematosus (SLE) and the production of antibodies to dsDNA. The study included 223 SLE patients attending the outpatient clinics at Helsinki University Central Hospital. The history of smoking was obtained by personal interview, and clinical data related to SLE by interview, clinical examination and chart review. The activity of SLE was assessed by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score and permanent damage by the SLICC/ACR score. Antibodies to dsDNA were determined by three ELISA assays, by the indirect immunofluorescence technique using Crithidia luciliae cells as substrates and by the Farr assay. There were no significant differences in the SLEDAI scores between current smokers (73 patients), ex-smokers (59) and never-smokers (91), though current smokers tended to have lower disease activity. The SLICC/ACR scores between the groups were practically equal. Current smokers had significantly lower levels of antibodies to dsDNA than ex- and never-smokers (p = 0.025). Our study suggests that cigarette smoke may have immunosuppressive effect on autoantibody production in patients with SLE. Permanent damage was not found to be associated with smoking.
AuthorsSusanne Ekblom-Kullberg, Hannu Kautiainen, Pirkko Alha, Marjatta Leirisalo-Repo, Aaro Miettinen, Heikki Julkunen
JournalRheumatology international (Rheumatol Int) Vol. 34 Issue 3 Pg. 341-5 (Mar 2014) ISSN: 1437-160X [Electronic] Germany
PMID24170320 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Complement C3
  • DNA
Topics
  • Adult
  • Autoantibodies (blood)
  • Complement C3 (metabolism)
  • DNA (immunology)
  • Female
  • Humans
  • Immunosuppression Therapy
  • Lupus Erythematosus, Systemic (blood, immunology)
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Smoking (adverse effects, immunology)
  • Smoking Cessation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: